AlphaStocks
5.0
Consider Buy

Viatris Inc (VTRS)

As of Sep 20, 2026, Viatris Inc (VTRS) scores 5.0/10 on AlphaStocks' five-model composite, #115 of 168 Health Care stocks. At $17, VTRS trades 15% below its model fair value of $20.

Health Care / Pharmaceuticals

S&P 500

$16.93

Below average on several measures. Research carefully.

Consider Buy

Score based on 2 of 5 models — limited data

Data as of Sep 20, 2026

#115out of 168 in Health Care

Is Viatris Inc a Good Investment in 2026?

Viatris Inc (VTRS) scores 5.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Viatris Inc as Attractive. However, the Buffett model rates it Caution. Viatris Inc currently trades 15% below its estimated fair value of $20. Viatris Inc ranks #115 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE114.4Market Cap20B

Estimated Fair Value

$20.0015% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Limited Data

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Viatris Inc (VTRS) a good investment?
As of Sep 20, 2026, Viatris Inc (VTRS) scores 5.0/10 on AlphaStocks' five-model composite, #115 of 168 Health Care stocks. At $17, VTRS trades 15% below its model fair value of $20. That score is below average, suggesting caution.
What is Viatris Inc's Piotroski F-Score?
Viatris Inc's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is VTRS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $20, VTRS appears undervalued. The stock currently trades 15% below its estimated fair value. Trading below estimated fair value.
How does VTRS compare to other Health Care stocks?
Viatris Inc ranks #115 out of 168 stocks in the Health Care sector, placing it in the top 68% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about VTRS?
AlphaStocks evaluates VTRS using five proven investment models. Piotroski: Neutral; Buffett: Caution; Lynch: Attractive. These models are combined into a single composite score of 5.0/10.

Similar Stocks

AMPHLLYACAD

Compare VTRS with

AMPH vs VTRSLLY vs VTRSACAD vs VTRSKLIC vs VTRSVAL vs VTRSAZN vs VTRSPARR vs VTRS

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer